Grants and Contributions:
Title:
A Rapid Test Combining Direct Detection with Immunity Monitoring to Address Every Stage of Pandemic Management
Agreement Number:
952810
Agreement Value:
$300,000.00
Agreement Date:
Jun 8, 2020 - Nov 30, 2021
Description:
Current COVID-19 diagnostics are lacking a complete picture of the disease and have limited sensitivity. Sensoreal’s solution would be the first serological immunity test combined with direct detection of the virus from a nasal swab in an accurate and portable system.
This solution adds the benefits of direct detection to the promise of immunity monitoring. The ideal diagnostic would not only limit the spread of the disease, but also help to manage it and foster long-term economic recovery.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H3N 1Y4
Reference Number:
172-2020-2021-Q2-952810
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
806119111
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 76 days.
Amendment Date
Sep 9, 2021
Recipient's Legal Name:
Sensoreal Inc.
Federal Riding Name:
Papineau
Federal Riding Number:
24055
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: